Our results showed that the mRNA levels of the CTHRC1 gene were decreased after treatment with sera from patients with spontaneous regression of malignant disease with high titres of anti‐CA I autoantibodies in all four tested tumour cell lines. The gene discussed is CTHRC1; the disease is neoplasm.